When should dialysis be stopped in patients with intradialytic hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Stop Dialysis in Intradialytic Hypertension

Dialysis should NOT be routinely stopped when intradialytic hypertension occurs; instead, continue the session while implementing management strategies focused on volume removal and dry weight optimization. 1, 2

Understanding Intradialytic Hypertension

Intradialytic hypertension is defined as a systolic blood pressure increase >10 mm Hg from pre- to post-dialysis, affecting 5-15% of hemodialysis patients. 1, 3 This condition is independently associated with increased hospitalization and mortality risk comparable to severe intradialytic hypotension, making it a serious cardiovascular complication that requires management rather than session termination. 1, 3

Why Dialysis Should Continue

The blood pressure rise during dialysis reflects chronic volume overload, sympathetic nervous system overactivity, and vascular resistance surges—not an acute emergency requiring immediate cessation. 1, 4 Patients with intradialytic hypertension typically have significant chronic extracellular volume excess despite small interdialytic weight gains, meaning they need continued ultrafiltration rather than session termination. 3, 5

Immediate Management During the Session

When intradialytic hypertension is identified during a dialysis session:

  • Continue ultrafiltration to achieve the prescribed dry weight target, as volume removal remains the cornerstone of management even when blood pressure rises. 1, 6

  • Do not reduce ultrafiltration rate unless there are signs of acute volume depletion (severe cramping, symptomatic hypotension upon standing, or clinical evidence of hypovolemia). 6, 7

  • Monitor for symptoms rather than stopping based on blood pressure numbers alone, as the elevated post-dialysis pressure reflects the underlying pathophysiology requiring treatment. 1, 2

Post-Session Management Algorithm

After identifying intradialytic hypertension, implement the following systematic approach:

Step 1: Volume Assessment and Dry Weight Challenge

  • Immediately initiate out-of-unit blood pressure measurements (home or ambulatory monitoring) to assess true interdialytic burden. 1
  • Aggressively challenge and reduce dry weight over subsequent sessions (typically 4-12 weeks, potentially up to 6-12 months for patients with diabetes or cardiomyopathy). 6, 1
  • Continue this gradual dry weight reduction until the intradialytic hypertension pattern normalizes or clinical signs of volume depletion appear. 1, 6

Step 2: Dialysate Modification

  • Lower dialysate sodium concentration, as this is the only controlled intervention proven to interrupt the blood pressure increase during dialysis. 1, 3, 5
  • Consider longer or more frequent dialysis sessions to achieve better volume control without excessive ultrafiltration rates. 1, 6

Step 3: Medication Optimization

  • Prioritize nondialyzable antihypertensive agents, particularly beta-blockers with vasodilatory properties (such as carvedilol). 1, 4, 5
  • Add ACE inhibitors or angiotensin receptor blockers to inhibit the renin-angiotensin-aldosterone system, as these agents cause greater regression of left ventricular hypertrophy. 1, 6
  • Administer antihypertensive medications preferentially at night to reduce nocturnal blood pressure surge and minimize intradialytic hypotension risk. 1, 6
  • Avoid dialyzable antihypertensive medications that may be removed during the session. 6, 8

Step 4: Dietary Intervention

  • Implement strict dietary sodium restriction (2-3 g/day) with regular counseling by dietitians. 6, 1
  • This reduces interdialytic fluid accumulation and allows for more effective volume control. 6

Critical Pitfalls to Avoid

Do not mistake intradialytic hypertension for a reason to stop dialysis or reduce ultrafiltration. The elevated blood pressure during dialysis reflects chronic volume overload that requires continued aggressive fluid removal, not session termination. 1, 3

Do not assume patients with small interdialytic weight gains are euvolemic. Bioimpedance spectroscopy shows these patients have significant chronic extracellular volume excess despite appearing clinically dry. 3, 5

Do not stop the dry weight probing process prematurely. Blood pressure may continue to decrease for 8 months or longer after extracellular fluid volume normalizes—this "lag phenomenon" means persistence is required. 6

When to Actually Consider Stopping Dialysis

Dialysis should only be stopped for:

  • Symptomatic hypotension with systolic blood pressure <90 mm Hg despite position changes and reduced ultrafiltration rate. 2
  • Severe muscle cramping unresponsive to reduced ultrafiltration rate. 6
  • Clinical evidence of acute volume depletion (orthostatic symptoms, altered mental status from cerebral hypoperfusion). 6
  • Other acute complications unrelated to blood pressure (chest pain, arrhythmias, access problems). 6

Elevated blood pressure alone during or after dialysis is NOT an indication to stop the session. 1, 2

References

Guideline

Management of Intradialytic Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Blood Pressure Trends Variable with Hemodialysis: Definition and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pathophysiology and implications of intradialytic hypertension.

Current opinion in nephrology and hypertension, 2017

Research

Intradialytic Hypertension in Maintenance Hemodialysis.

Current hypertension reports, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.